Discounted Cash Flow (DCF) Analysis Unlevered
Repligen Corporation (RGEN)
$167.26
+0.19 (+0.11%)
All numbers are in Millions, Currency in USD
Operating Data
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 194.03 | 270.25 | 366.26 | 670.53 | 801.54 | 1,157.06 | 1,670.27 | 2,411.12 | 3,480.58 | 5,024.39 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue (%) | ||||||||||
EBITDA | 43.92 | 56.31 | 98.42 | 204.70 | 271.29 | 311.76 | 450.04 | 649.65 | 937.80 | 1,353.76 |
EBITDA (%) | ||||||||||
EBIT | 28.15 | 35.44 | 71.35 | 166.26 | 220.30 | 229.98 | 331.99 | 479.24 | 691.81 | 998.66 |
EBIT (%) | ||||||||||
Depreciation | 15.78 | 20.87 | 27.07 | 38.45 | 50.98 | 81.78 | 118.05 | 170.41 | 246 | 355.11 |
Depreciation (%) |
Balance Sheet Data
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Total Cash | 193.82 | 528.39 | 717.29 | 603.81 | 623.76 | 1,525.30 | 2,201.84 | 3,178.47 | 4,588.29 | 6,623.43 |
---|---|---|---|---|---|---|---|---|---|---|
Total Cash (%) | ||||||||||
Account Receivables | 35.75 | 43.67 | 71.39 | 117.42 | 116.25 | 199.23 | 287.60 | 415.16 | 599.30 | 865.12 |
Account Receivables (%) | ||||||||||
Inventories | 42.26 | 54.83 | 95.02 | 184.49 | 238.28 | 289.86 | 418.43 | 604.02 | 871.94 | 1,258.69 |
Inventories (%) | ||||||||||
Accounts Payable | 10.49 | 11.42 | 16.88 | 36.20 | 27.55 | 53.41 | 77.10 | 111.29 | 160.66 | 231.92 |
Accounts Payable (%) | ||||||||||
Capital Expenditure | -14.04 | -23.15 | -26.34 | -71.28 | -88.35 | -103.32 | -149.14 | -215.30 | -310.79 | -448.64 |
Capital Expenditure (%) |
Weighted Average Cost Of Capital
Share price | $ 167.26 |
---|---|
Beta | 1.078 |
Diluted Shares Outstanding | 57.45 |
Cost of Debt | |
Tax Rate | 15.14 |
After-tax Cost of Debt | 0.23% |
Risk-Free Rate | |
Market Risk Premium | |
Cost of Equity | 8.781 |
Total Debt | 422.96 |
Total Equity | 9,609.92 |
Total Capital | 10,032.88 |
Debt Weighting | 4.22 |
Equity Weighting | 95.78 |
Wacc |
Build Up Free Cash
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 194.03 | 270.25 | 366.26 | 670.53 | 801.54 | 1,157.06 | 1,670.27 | 2,411.12 | 3,480.58 | 5,024.39 |
---|---|---|---|---|---|---|---|---|---|---|
EBITDA | 43.92 | 56.31 | 98.42 | 204.70 | 271.29 | 311.76 | 450.04 | 649.65 | 937.80 | 1,353.76 |
EBIT | 28.15 | 35.44 | 71.35 | 166.26 | 220.30 | 229.98 | 331.99 | 479.24 | 691.81 | 998.66 |
Tax Rate | 22.48% | 18.13% | -1.20% | 16.45% | 15.14% | 14.20% | 14.20% | 14.20% | 14.20% | 14.20% |
EBIAT | 21.82 | 29.02 | 72.20 | 138.91 | 186.95 | 197.32 | 284.85 | 411.19 | 593.57 | 856.85 |
Depreciation | 15.78 | 20.87 | 27.07 | 38.45 | 50.98 | 81.78 | 118.05 | 170.41 | 246 | 355.11 |
Accounts Receivable | - | -7.92 | -27.72 | -46.03 | 1.17 | -82.98 | -88.37 | -127.56 | -184.14 | -265.82 |
Inventories | - | -12.57 | -40.19 | -89.47 | -53.78 | -51.58 | -128.57 | -185.59 | -267.92 | -386.75 |
Accounts Payable | - | 0.94 | 5.46 | 19.32 | -8.65 | 25.85 | 23.69 | 34.20 | 49.36 | 71.26 |
Capital Expenditure | -14.04 | -23.15 | -26.34 | -71.28 | -88.35 | -103.32 | -149.14 | -215.30 | -310.79 | -448.64 |
UFCF | 23.56 | 7.18 | 10.47 | -10.09 | 88.33 | 67.07 | 60.50 | 87.34 | 126.08 | 182.01 |
WACC | ||||||||||
PV UFCF | 61.86 | 51.47 | 68.53 | 91.25 | 121.49 | |||||
SUM PV UFCF | 394.60 |
Terminal Value
Growth in perpetuity method: | |
---|---|
Long-term growth rate | |
WACC (%) | 8.42 |
Free cash flow (t + 1) | 185.65 |
Terminal Value | 2,891.67 |
Present Value of Terminal Value | 1,930.20 |
Intrinsic Value
Enterprise Value | 2,324.80 |
---|---|
Net Debt | -100.50 |
Equity Value | 2,425.30 |
Shares Outstanding | 57.45 |
Equity Value Per Share | 42.21 |